APA

Mücke V. T., Mücke M. M., Peiffer K., Weiler N., Welzel T. M., Sarrazin C., Zeuzem S., Berger A. & Vermehren J. (20171207). No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort. : Alimentary pharmacology & therapeutics.

Chicago

Mücke V T, Mücke M M, Peiffer K-H, Weiler N, Welzel T M, Sarrazin C, Zeuzem S, Berger A and Vermehren J. 20171207. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort. : Alimentary pharmacology & therapeutics.

Harvard

Mücke V. T., Mücke M. M., Peiffer K., Weiler N., Welzel T. M., Sarrazin C., Zeuzem S., Berger A. and Vermehren J. (20171207). No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort. : Alimentary pharmacology & therapeutics.

MLA

Mücke V T, Mücke M M, Peiffer K-H, Weiler N, Welzel T M, Sarrazin C, Zeuzem S, Berger A and Vermehren J. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort. : Alimentary pharmacology & therapeutics. 20171207.